- Marinomeds new Carragelose eye drops improve dry eye-related symptoms in patients with mild to moderate dry eye syndrome by remarkable 54%
- Product was well tolerated by patients and ocular surface disease index (OSDI) was significantly reduced
- Eye drops hold valid Medical Device Directive (MDD) certificate and are in transition phase for the new Medical Device Regulation (MDR) – launch preparations for 2024
The full press release is available as download here: